Antithrombotic therapy in patients with recent stroke and atrial fibrillation.

Antithrombotic therapy in patients with recent stroke and atrial fibrillation.
Curr Pharm Des. 2020 Apr 07;:
Authors: Saberwal B, Ioannou A, Lim WY, Beirne AM, Chow AW, Tousoulis D, Ahsan S, Papageorgiou N
Abstract
Atrial fibrillation (AF) is a common arrhythmia which carries a significant risk of stroke. Secondary prevention, in particular in the acute phase of stroke with anti-thrombotic therapy has not been validated. The aim of this review is to evaluate the available evidence on the use of antithrombotic therapy in patients with recent stroke who have AF, and suggest a treatment algorithm for the various time points, taking into account both the bleeding and thrombosis risks posed at each stage.
PMID: 32264805 [PubMed - as supplied by publisher]

Source: Current Pharmaceutical Design - April 6, 2020 Category: Drugs & Pharmacology Authors: Saberwal B, Ioannou A, Lim WY, Beirne AM, Chow AW, Tousoulis D, Ahsan S, Papageorgiou N Tags: Curr Pharm Des Source Type: research